Additional information
| Active substance | Tirzepatide |
|---|---|
| Active Half-Life | 5 days |
| Classification | Dual GIP and GLP-1 Receptor Agonist |
| Hepatotoxicity | No significant hepatotoxicity reported |
| Lab Test | Monitoring blood glucose levels and HbA1c |
| Also known as | LY3298176 |
| WAREHOUSE | International Warehouse 3 |
| Blood pressure | May reduce blood pressure |
| Trade name | Mounjaro |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F), protect from light |
| Chemical name | Tirzepatide |
| Formula | C225H348N48O68 |
| Substance class | Glucagon-like peptide-1 (GLP-1) receptor agonists |
| Main action | Lowers blood glucose levels |
| Half-life | Approximately 5 days |
| Dosage (medical) | Typically started at 2.5 mg once weekly, can be increased to 5 mg, 10 mg, or 15 mg once weekly depending on response and tolerability |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Effects | Improves glycemic control, promotes weight loss |
| Side effects | Nausea, diarrhea, decreased appetite, vomiting, constipation |
| Use in sports | None, not used for performance enhancement |
| Manufacturer | Nakon Medical |
LACIPIL 4 mg Glaxosmithkline
Clen 40 SINGANI PHARMA
Norvacs 5 mg Pfizer
Balkan Pharma Danabol 50 mg 60 Tabletten
Thyromazol 5 mg Abdi Ibragim
Bvs Labs Dianabol 10mg 100 Tabletten
Spiriva HandiHaler 18mg Boehringer Ingelheim
Prograf 5mg Astellas Pharma
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Champix Starter Pack Pfizer
Rovamycine 3.000.000 iu Eczacibasi
Prograf 1mg Astellas Pharma
AVELOX 400 Bayer
Clenbuterol 40 Maha Pharma
Muscoflex 8 mg Bilim
FACTIVE 320 mg Abdi Ibragim
Sp Labs Lipo-Feuer 10ml
Tavanic 500 mg Sanofi
Januvia 100mg Merckgroup
Zyban Glaxosmithkline
Clenbutaxyl Kalpa Pharmaceuticals 

Reviews
There are no reviews yet.